HYAL1 and ovarian carcinoma: The present findings of reduced HYAL1 expression are consistent with those of another set of ovarian cancer samples [3], but in a strong contrast to reports on prostate and bladder tumors in which increased HYAL1 expression in poorly differentiated tumors is associated with advanced disease and unfavorable prognosis [15,16].